Colgate-Palmolive reported Q2 2024 revenue of $5.1B, beat analyst consensus of $5.0B by $53.7M. Diluted EPS came in at $0.91, beat the $0.87 consensus by $0.04. Colgate-Palmolive reports across 4 business segments, led by Oral Care, Personal Care, and Home Care.
Trailing eight quarters through Q2 2024
Common questions about Colgate-Palmolive's Q2 2024 earnings report.
Colgate-Palmolive (CL) reported Q2 2024 earnings on July 26, 2024 before market open.
Colgate-Palmolive reported revenue of $5.1B and diluted EPS of $0.91 for Q2 2024.
Revenue beat the consensus estimate of $5.0B by $53.7M. EPS beat the consensus estimate of $0.87 by $0.04.
You can read the 10-Q periodic report (0000021665-24-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.